March 6, listed on the NYSE in the US, one of the Big Three Chinese medical equipment Mindray Medical (Mindray Medical International) announced that it has completed 3.3 billion US dollars worth of privatization transactions. The completion of the $28 per share transaction means that Mindray Medical’s stock MR on the New York Stock Exchange will terminate the transaction. Mindray Medical co-CEO Li Xiting and Cheng Minghe and Chairman Xu Hang have offered $30 per share for privatization in June 2015, or $3.5 billion. The three then lowered their offer to $27 per share, or $3.15 billion, and eventually reached an agreement in November last year for the price of 28 yuan per share. Prior to the start of the transaction, Li Xiting, Cheng Minghe and Xu Hang and their controlled entities already held the voting shares of Mindray 63.7. Mindray's road to privatization Mindray was listed in the US in September 2006. On June 4, 2015, Mindray Medical announced the privatization process. At that time, the president of the group Li Xiting, chairman Xu Hang, and the chief strategy officer Cheng Ming and the three-person buyer group gave the purchase price of 30 dollars. Unlike many US stock companies that initiated privatization offer companies during the same period, Mindray Medical’s buyer group did not have private equity funds, and the company’s management initiated the offer. Mindray’s privatization funds were mainly from bank loans, and it was intended to borrow from banks. One hundred million U.S. dollars. However, shortly after Mindray Medical initiated the privatization offer, the global capital market fluctuated sharply, and the stock price of China Stock Exchange plummeted. After June 4, 2015, Mindray’s share price has fluctuated and has fallen to US$24 in September. The privatization offer premium has increased to 24%, in view of the fact that Mindray’s three management shareholding ratio is 27.7%, if the privatization price is not adjusted, the financing cost will be very high. On September 10, Mindray Medical announced that the three managements submitted a revised privatization offer to the board of directors, and the offer price was lowered to $27. Became the first company to lower the privatization offer in 2015, sparking market discussions and thought it might affect other privatized companies to lower their offer. On the day the Mindray Medical lowered its offer, the company's share price hit a 52-week low, falling more than 2% to $23.51. On September 30, Mindray's share price once fell to 21.80 US dollars, and then hit a new low. According to a report released by Mindray last year, the company's net income in 2014 was $1.3 billion, an increase of 9.0% over the previous year. Among them, sales in China accounted for about half of the company's total revenue, which was $606.7 million, an increase of 10.1% year-on-year. Sales in overseas markets increased by 8.0% to $716.1 million. However, despite good revenues, Mindray's P/E ratio is 18 times, but the average valuation of similar companies in the A-share market is 58 times. This is also one of the important reasons why Mindray has been rumored to return to the domestic stock market in the United States. Pain Relief Patch For Neck Shoulder,Lower Back And Leg
Pain Relief Patch for neck shoulder, lower back and leg.
Pain Relief Patch,Pain Relief Pad,Pain Relief Plaster,Neck Pain Relief Patch,Back Pain Relief Pacth Shandong XiJieYiTong International Trade Co.,Ltd. , https://www.xijieyitongpatches.com
[Name] Medical Cold Patch
[Package Dimension] 10cm×12cm 2pieces/box
The pain relief patch is composed of three layers, namely, backing lining, middle gel and protective film. It is free from pharmacological, immunological or metabolic ingredients.
[Scope of Application] For cold physiotherapy, closed soft tissue only.
[Indications]
The patches give fast acting pain relief for strains, sprains, cramp, bruises, swollen areas or joint stiffness.
[How To Use a Patch]
Tear off the packaging bag and remove the patch. Remove the protective film and apply the patch on the skin. One piece, one time. The curing effect of each piece can last for 8-12 hours.
[Attention]
Do not apply the patch on the problematic skin, such as wounds, eczema, dermatitis,or in the eyes. People allergic to herbs and the pregnant are advised not to use the medication. If swelling or irritation occurs, please stop using and if any of these effects persist or worsen.notify your doctor or pharmacist promptly. Children using the patch must be supervised by adults.
[Storage Conditions]
Store below 30c in a dry place away from heat and direct sunlight.